Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
19.08
-0.47 (-2.40%)
At close: Jun 6, 2025, 4:00 PM
18.51
-0.57 (-2.99%)
After-hours: Jun 6, 2025, 7:48 PM EDT

Beta Bionics Statistics

Total Valuation

Beta Bionics has a market cap or net worth of $827.24 million. The enterprise value is $602.74 million.

Market Cap 827.24M
Enterprise Value 602.74M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, before market open.

Earnings Date Aug 6, 2025
Ex-Dividend Date n/a

Share Statistics

Beta Bionics has 43.36 million shares outstanding. The number of shares has increased by 150.89% in one year.

Current Share Class 43.36M
Shares Outstanding 43.36M
Shares Change (YoY) +150.89%
Shares Change (QoQ) +360.80%
Owned by Insiders (%) 3.71%
Owned by Institutions (%) 62.60%
Float 26.20M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.43
Forward PS 8.62
PB Ratio 2.64
P/TBV Ratio 2.64
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 8.63
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 15.88, with a Debt / Equity ratio of 0.02.

Current Ratio 15.88
Quick Ratio 14.58
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -16.93%
Revenue Per Employee $237,517
Profits Per Employee -$241,371
Employee Count 294
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 13.07
200-Day Moving Average n/a
Relative Strength Index (RSI) 67.94
Average Volume (20 Days) 566,055

Short Selling Information

The latest short interest is 3.56 million, so 8.20% of the outstanding shares have been sold short.

Short Interest 3.56M
Short Previous Month 3.54M
Short % of Shares Out 8.20%
Short % of Float 13.57%
Short Ratio (days to cover) 0.05

Income Statement

In the last 12 months, Beta Bionics had revenue of $69.83 million and -$70.96 million in losses. Loss per share was -$5.66.

Revenue 69.83M
Gross Profit 37.66M
Operating Income -54.44M
Pretax Income -55.50M
Net Income -70.96M
EBITDA -53.27M
EBIT -54.44M
Loss Per Share -$5.66
Full Income Statement

Balance Sheet

The company has $231.47 million in cash and $6.97 million in debt, giving a net cash position of $224.50 million or $5.18 per share.

Cash & Cash Equivalents 231.47M
Total Debt 6.97M
Net Cash 224.50M
Net Cash Per Share $5.18
Equity (Book Value) 313.75M
Book Value Per Share 7.24
Working Capital 245.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$56.10 million and capital expenditures -$3.32 million, giving a free cash flow of -$59.43 million.

Operating Cash Flow -56.10M
Capital Expenditures -3.32M
Free Cash Flow -59.43M
FCF Per Share -$1.37
Full Cash Flow Statement

Margins

Gross margin is 53.93%, with operating and profit margins of -77.96% and -101.62%.

Gross Margin 53.93%
Operating Margin -77.96%
Pretax Margin -101.62%
Profit Margin -101.62%
EBITDA Margin -76.29%
EBIT Margin -77.96%
FCF Margin n/a

Dividends & Yields

Beta Bionics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -150.89%
Shareholder Yield -150.89%
Earnings Yield -8.58%
FCF Yield -7.18%

Analyst Forecast

The average price target for Beta Bionics is $24.50, which is 28.41% higher than the current price. The consensus rating is "Buy".

Price Target $24.50
Price Target Difference 28.41%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Beta Bionics has an Altman Z-Score of 18.97 and a Piotroski F-Score of 2.

Altman Z-Score 18.97
Piotroski F-Score 2